Hyperfine (HYPR) Competitors

$0.89
+0.05 (+5.93%)
(As of 05/17/2024 ET)

HYPR vs. ECOR, MOVE, POCI, PXDT, VANI, FONR, NRXS, QTI, ELMD, and SMLR

Should you be buying Hyperfine stock or one of its competitors? The main competitors of Hyperfine include electroCore (ECOR), Movano (MOVE), Precision Optics (POCI), Pixie Dust Technologies (PXDT), Vivani Medical (VANI), FONAR (FONR), NeurAxis (NRXS), QT Imaging (QTI), Electromed (ELMD), and Semler Scientific (SMLR). These companies are all part of the "electromedical equipment" industry.

Hyperfine vs.

Hyperfine (NASDAQ:HYPR) and electroCore (NASDAQ:ECOR) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, media sentiment, profitability, dividends, community ranking, earnings, risk and institutional ownership.

Hyperfine has a beta of 0.82, meaning that its share price is 18% less volatile than the S&P 500. Comparatively, electroCore has a beta of 0.91, meaning that its share price is 9% less volatile than the S&P 500.

electroCore has a net margin of -88.12% compared to Hyperfine's net margin of -358.59%. Hyperfine's return on equity of -46.96% beat electroCore's return on equity.

Company Net Margins Return on Equity Return on Assets
Hyperfine-358.59% -46.96% -42.42%
electroCore -88.12%-219.33%-102.44%

15.0% of Hyperfine shares are held by institutional investors. Comparatively, 26.7% of electroCore shares are held by institutional investors. 26.5% of Hyperfine shares are held by company insiders. Comparatively, 13.1% of electroCore shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

In the previous week, Hyperfine had 11 more articles in the media than electroCore. MarketBeat recorded 12 mentions for Hyperfine and 1 mentions for electroCore. electroCore's average media sentiment score of 0.90 beat Hyperfine's score of 0.40 indicating that electroCore is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Hyperfine
1 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
electroCore
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

electroCore has higher revenue and earnings than Hyperfine. electroCore is trading at a lower price-to-earnings ratio than Hyperfine, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hyperfine$11.03M5.83-$44.24M-$0.59-1.51
electroCore$16.03M2.62-$18.83M-$2.85-2.46

Hyperfine currently has a consensus target price of $2.12, suggesting a potential upside of 137.00%. Given Hyperfine's higher probable upside, equities research analysts plainly believe Hyperfine is more favorable than electroCore.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hyperfine
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33
electroCore
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

electroCore received 160 more outperform votes than Hyperfine when rated by MarketBeat users. Likewise, 62.12% of users gave electroCore an outperform vote while only 44.44% of users gave Hyperfine an outperform vote.

CompanyUnderperformOutperform
HyperfineOutperform Votes
4
44.44%
Underperform Votes
5
55.56%
electroCoreOutperform Votes
164
62.12%
Underperform Votes
100
37.88%

Summary

electroCore beats Hyperfine on 9 of the 17 factors compared between the two stocks.

Get Hyperfine News Delivered to You Automatically

Sign up to receive the latest news and ratings for HYPR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HYPR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HYPR vs. The Competition

MetricHyperfineElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$64.26M$3.37B$5.32B$7.96B
Dividend YieldN/A1.65%44.08%3.91%
P/E Ratio-1.519.34137.8017.70
Price / Sales5.8364.972,351.8375.92
Price / CashN/A69.8736.8131.88
Price / Book0.854.415.744.76
Net Income-$44.24M$87.99M$108.91M$217.17M
7 Day Performance13.05%1.47%1.42%2.90%
1 Month Performance7.60%1.28%4.95%6.66%
1 Year Performance-30.23%1.92%7.81%9.89%

Hyperfine Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ECOR
electroCore
0 of 5 stars
$7.61
+5.0%
N/A+16.7%$43.54M$16.03M-2.6768Gap Down
High Trading Volume
MOVE
Movano
0 of 5 stars
$0.42
flat
N/A-57.2%$41.17MN/A-0.6434Gap Down
POCI
Precision Optics
0 of 5 stars
$6.13
-0.5%
N/A+2.4%$37.21M$21.05M-20.4384News Coverage
PXDT
Pixie Dust Technologies
2.1993 of 5 stars
$2.53
+3.3%
$5.21
+105.9%
N/A$37.20M$845.21M0.0078Gap Up
VANI
Vivani Medical
0 of 5 stars
$1.83
-1.1%
N/A+54.7%$100.61MN/A-3.6644Upcoming Earnings
News Coverage
FONR
FONAR
0 of 5 stars
$16.45
+1.3%
N/A-10.0%$104.13M$98.64M8.94561Upcoming Earnings
NRXS
NeurAxis
0 of 5 stars
$3.00
-0.3%
N/AN/A$19.77M$2.46M-0.6517News Coverage
QTI
QT Imaging
0 of 5 stars
$0.86
+1.2%
N/AN/A$18.49MN/A0.00N/ANews Coverage
ELMD
Electromed
0 of 5 stars
$16.87
-1.4%
N/A+35.4%$146.09M$48.07M33.74170
SMLR
Semler Scientific
0 of 5 stars
$23.50
+1.8%
N/A-22.2%$166.15M$68.18M8.4292

Related Companies and Tools

This page (NASDAQ:HYPR) was last updated on 5/19/2024 by MarketBeat.com Staff

From Our Partners